Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
SNDX —
Syndax Pharmaceuticals
CUSIP: 87164F105 · Held by 3 superinvestors · Combined value: $21,239,114
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $11,446,248 | 544,800 | REDUCE | -315,700 |
| 2 | Ken Griffin | 0.0% | $7,738,046 | 368,303 | REDUCE | -354,665 |
| 3 | Torray LLC | 0.3% | $2,054,820 | 97,802 | NEW BUY | +97,802 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Torray LLC | NEW BUY | +97,802 | New |
| Jim Simons | REDUCE | -315,700 | -36.7% |
| Ken Griffin | REDUCE | -354,665 | -49.1% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +22,800 | +2.7% |
| Ken Griffin | REDUCE | -49,932 | -6.5% |
Who Owns SNDX? Superinvestor Holdings
Syndax Pharmaceuticals is held by 3 tracked superinvestors, with a combined position value of $21 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio), Torray LLC (0.3% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 2 reduced or exited.